| 1 | Presentation and, if applicable, approval of the reports referred to in Article 28, Section IV of the Securities Market Law, including the presentation of the Company's financial statements for the fiscal year ended December 31, 2025 | Oppose |
| 2 | Presentation of the report on the Company's compliance with its tax obligations, in accordance with applicable legal provisions | Oppose |
| 3 | Resolutions on the appropriation of profits for the fiscal year ended December 31, 2025, including the declaration and payment of dividends | Oppose |
| 4.1 | The amount that may be allocated to the repurchase of the Company's own shares, pursuant to Article 56, Section IV of the Securities Market Law | Oppose |
| 4.2 | The report on the policies and resolutions adopted by the Company's Board of Directors in connection with the purchase and sale of such shares | Oppose |
| 5 | Appointment and/or ratification, as applicable, of the members of the Board of Directors, the Secretary, and the Chief Executive Officer | Oppose |
| 6 | Appointment and/or ratification, as applicable, of the Chair of the Audit and Corporate Practices Committee and the Secretary | Abstain |
| 7 | Determination of the remuneration of the members of the Board of Directors and the Audit and Corporate Practices Committee, as well as of the Secretary | Abstain |
| 8 | Approval for the issuance before a notary public of a certified extract of the Company's by-laws, in accordance with Article 34, Section V of the General Provisions applicable to Issuers of Securities and other participants in the Securities Market | For |
| 9 | Revocation of powers of attorney | For |
| 10 | Appointment of delegates to carry out and formalize the resolutions adopted by this Meeting | For |
